# Graviti Pharmaceuticals Private Limited, Hyderabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/graviti-pharmaceuticals-private-limited/767496b4-6b24-44f3-ad5a-7dcf4399b2e2

> Inspection records and compliance data for Graviti Pharmaceuticals Private Limited in Hyderabad. 4 FDA inspections on record, 3 Form 483s, last inspected July 28, 2026.

---

## Details

- Name: Graviti Pharmaceuticals Private Limited
- FEI Number: 3012932394
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: E & 621 Patancheru Mandal, Isnapur Village Rd; Survey No 621
- City: Hyderabad
- Country Name: India
- Address: E & 621 Patancheru Mandal, Isnapur Village Rd; Survey No 621, Hyderabad, India
- Country: India

## Related Documents

- [483 - Graviti Pharmaceuticals Private Limited - 2026-07-28](https://www.keypedia.com/records/483/graviti-pharmaceuticals-private-limited/f17100b6-c419-4332-b1a4-0328f13d7638) — source: FDA, date: July 28, 2026
- [FDA Inspection 1329590 - Graviti Pharmaceuticals Private Limited - 2026-07-28](https://www.keypedia.com/records/fda_inspections/graviti-pharmaceuticals-private-limited/cd7314df-6823-4dec-8ec5-868f44c01082) — source: FDA, date: July 28, 2026
- [EMA GMP - Graviti Pharmaceuticals Private Limited - MT/001NCR/2024 - 2024-05-06](https://www.keypedia.com/records/ema/graviti-pharmaceuticals-private-limited/e601e80c-3246-4962-96f3-9b3e4c2cb0b8) — source: EMA, date: May 6, 2024
- [FDA Inspection 1199883 - Graviti Pharmaceuticals Private Limited - 2023-02-03](https://www.keypedia.com/records/fda_inspections/graviti-pharmaceuticals-private-limited/0b0764cc-8d17-41f5-83bc-f3c6819f59e8) — classification: No Action Indicated (NAI), source: FDA, date: February 3, 2023
- [FDA Inspection 1048321 - Graviti Pharmaceuticals Private Limited - 2018-04-13](https://www.keypedia.com/records/fda_inspections/graviti-pharmaceuticals-private-limited/1c227969-cd4d-4a59-995b-2214adb51d00) — source: FDA, date: April 13, 2018
- [FDA Inspection 1020610 - Graviti Pharmaceuticals Private Limited - 2017-08-04](https://www.keypedia.com/records/fda_inspections/graviti-pharmaceuticals-private-limited/bd3ccd3e-29bf-406e-9764-95749485b4ad) — source: FDA, date: August 4, 2017

## Related Companies

- [Astellas Pharma Inc.](https://www.keypedia.com/companies/astellas-pharma-inc/ad5c1a7d-23cf-412a-88ce-62ab257c3233)
- [Vetter Pharma Fertigung GmbH & Co. KG](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg/9c78f7c1-8016-4128-9dc3-ce5b4e0e0d44)
- [Catalent Pharma Solutions LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/1080c7fd-2536-4ea5-9a11-18fc6317081b)
- [Shire Human Genetic Therapies, Inc.](https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/7051823d-8cc7-4d72-8a82-a0de9bbb9497)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/4904f62e-dd42-4ea9-b381-cb6e5d44558d)
- [APL HEALTHCARE LIMITED](https://www.keypedia.com/companies/apl-healthcare-limited/d13ff022-135e-4790-b958-7f0667d985ab)
- [Sun Pharmaceuticals Industries Ltd.](https://www.keypedia.com/companies/sun-pharmaceuticals-industries-ltd/758af0ba-71ed-4144-b6c7-e175eaafa473)
- [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76)
- [MSN Laboratories Private Limited (Formulations Division, Unit-II)](https://www.keypedia.com/companies/msn-laboratories-private-limited-formulations-division-unit-ii/44914049-4b84-4bac-abac-9af09a223eb8)
- [Sentiss Pharma Private Ltd.](https://www.keypedia.com/companies/sentiss-pharma-private-ltd/9b26b814-70c1-46e9-bc82-9bec425fd2b7)

## Related Officers

- [John D. McIntosh](https://www.keypedia.com/people/john-d-mcintosh/063cac5b-0933-4ecf-a9fb-835dd5d25ef2)
- [issuing_officer](https://www.keypedia.com/people/khoa-nathan-v-tran/678e5634-237c-4395-88a1-7418479e83c7)